Asset Value Investors increases stake in Wakamoto Pharmaceutical to 11.64%
Asset Value Investors raised its stake in Wakamoto Pharmaceutical to 11.64% from 10.60%, according to a filing.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.